Sequential intraportal islet allografts in immunosuppressed type I diabetic patients: preliminary results.
Pattou
F
F
Department of General Surgery, Centre Hospitalier et Universitaire de Lille, Lille, France.
Vantyghem
M C
MC
Noel
C
C
Kerr-Conte
J
J
Gmyr
V
V
Martinache
I
I
Vandewalle
B
B
N'Guyen
H
H
Lecomte-Houcke
M
M
Lefebvre
J
J
Proye
C
C
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000601:surgery*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000379:methods* / Q000502:physiology*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011168:Portal System; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D009173:Mycophenolic Acid